NEW YORK (GenomeWeb News) – Cambridge, Mass.-based molecular diagnostics company IntelligentMDx has raised $3 million in a financing from two undisclosed investors, the company said on Tuesday.

The company will use the funds to develop tests for specific viral and bacterial nucleic acid targets using a proprietary bioinformatics approach. It makes molecular diagnostic test kits for transplantation, fungal infection, blood screening, meningitis/encephalitis, and respiratory disease.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

Feb
22
Sponsored by
SeraCare

This webinar will walk through key considerations and helpful guidelines to accelerate next-generation sequencing (NGS)-based clinical genomics assay validation for less money and greater confidence in results.

Mar
08
Sponsored by
Swift Biosciences

This webinar will discuss an optimized protocol for methyl-CpG binding domain sequencing (MBD-seq), which enables comprehensive, adequately powered, and cost-effective large-scale methylome-wide association studies (MWAS) of almost all 28 million CpG sites in the genome.

Mar
13
Sponsored by
Agilent

This webinar will share how clinical genetics labs can integrate cytogenetics and molecular data to assess abnormalities using a single sample on a single workflow platform.

Apr
03
Sponsored by
Dovetail Genomics

Proximity ligation technology generates multi-dimensional next-generation sequencing data that is proving to solve unmet needs in genomic research.